These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26804008)

  • 1. Reconciling paradigms of abnormal pulmonary blood flow and quasi-malignant cellular alterations in pulmonary arterial hypertension.
    Happé CM; Szulcek R; Voelkel NF; Bogaard HJ
    Vascul Pharmacol; 2016 Aug; 83():17-25. PubMed ID: 26804008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension.
    Xu W; Erzurum SC
    Compr Physiol; 2011 Jan; 1(1):357-72. PubMed ID: 23737177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial progenitor cells in pulmonary arterial hypertension.
    Diller GP; Thum T; Wilkins MR; Wharton J
    Trends Cardiovasc Med; 2010 Jan; 20(1):22-9. PubMed ID: 20685574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovine Models of Congenital Heart Disease and the Consequences of Hemodynamic Alterations for Pulmonary Artery Remodeling.
    Johnson Kameny R; Datar SA; Boehme JB; Morris C; Zhu T; Goudy BD; Johnson EG; Galambos C; Raff GW; Sun X; Wang T; Chiacchia SR; Lu Q; Black SM; Maltepe E; Fineman JR
    Am J Respir Cell Mol Biol; 2019 May; 60(5):503-514. PubMed ID: 30620615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.
    Sakao S; Tatsumi K; Voelkel NF
    Respir Res; 2009 Oct; 10(1):95. PubMed ID: 19825167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.
    Van Hung T; Emoto N; Vignon-Zellweger N; Nakayama K; Yagi K; Suzuki Y; Hirata K
    Life Sci; 2014 Nov; 118(2):313-28. PubMed ID: 24412382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport.
    Liu B; Azfar M; Legchenko E; West JA; Martin S; Van den Haute C; Baekelandt V; Wharton J; Howard L; Wilkins MR; Vangheluwe P; Morrell NW; Upton PD
    Cardiovasc Res; 2024 May; 120(7):756-768. PubMed ID: 38626311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular pathobiology of pulmonary arterial hypertension.
    Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occlusive lung arterial lesions in endothelial-targeted, fas-induced apoptosis transgenic mice.
    Goldthorpe H; Jiang JY; Taha M; Deng Y; Sinclair T; Ge CX; Jurasz P; Turksen K; Mei SH; Stewart DJ
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):712-8. PubMed ID: 25879383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.
    Szulcek R; Happé CM; Rol N; Fontijn RD; Dickhoff C; Hartemink KJ; Grünberg K; Tu L; Timens W; Nossent GD; Paul MA; Leyen TA; Horrevoets AJ; de Man FS; Guignabert C; Yu PB; Vonk-Noordegraaf A; van Nieuw Amerongen GP; Bogaard HJ
    Am J Respir Crit Care Med; 2016 Jun; 193(12):1410-20. PubMed ID: 26760925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension.
    Mandegar M; Fung YC; Huang W; Remillard CV; Rubin LJ; Yuan JX
    Microvasc Res; 2004 Sep; 68(2):75-103. PubMed ID: 15313118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets.
    Mercier O; Sage E; de Perrot M; Tu L; Marcos E; Decante B; Baudet B; Hervé P; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1538-46. PubMed ID: 19464477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microparticles in severe pulmonary arterial hypertension increase intercellular adhesion molecule-1 expression selectively in pulmonary artery endothelium.
    Blair LA; Haven AK; Bauer NN
    Respir Res; 2016 Oct; 17(1):133. PubMed ID: 27765042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible or irreversible remodeling in pulmonary arterial hypertension.
    Sakao S; Tatsumi K; Voelkel NF
    Am J Respir Cell Mol Biol; 2010 Dec; 43(6):629-34. PubMed ID: 20008280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.
    Dickinson MG; Bartelds B; Borgdorff MA; Berger RM
    Am J Physiol Lung Cell Mol Physiol; 2013 Jul; 305(1):L1-14. PubMed ID: 23624788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hyperproliferative endothelial cell phenotype in idiopathic pulmonary arterial hypertension.
    Stevens T; Gillespie MN
    Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L546-7. PubMed ID: 17601794
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
    Dai Z; Li M; Wharton J; Zhu MM; Zhao YY
    Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow.
    Datar SA; Johnson EG; Oishi PE; Johengen M; Tang E; Aramburo A; Barton J; Kuo HC; Bennett S; Xoinis K; Reel B; Kalkan G; Sajti E; Osorio O; Raff GW; Matthay MA; Fineman JR
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L530-40. PubMed ID: 22207591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.